MyAverix Finance
NS · Pharmaceuticals
Morepen Laboratories Ltd (MOREPENLAB)
Pharmaceuticals & Biotechnology
Morepen Laboratories Ltd (MOREPENLAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $28.60B, P/E ratio is 43.14, net margin is 5.8%, dividend yield is 0.38%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MOREPENLAB
Morepen Laboratories Ltd (MOREPENLAB) — FAQ
What is Morepen Laboratories Ltd's market cap?
Morepen Laboratories Ltd (MOREPENLAB) has a reported market cap of $28.60B (data as of 2026-07-10).
What is MOREPENLAB's P/E ratio?
The price-to-earnings (P/E) ratio for Morepen Laboratories Ltd (MOREPENLAB) is 43.14 (data as of 2026-07-10).
Does Morepen Laboratories Ltd pay a dividend?
Morepen Laboratories Ltd (MOREPENLAB) shows a reported dividend yield of 0.38%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Morepen Laboratories Ltd in?
Morepen Laboratories Ltd (MOREPENLAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is MOREPENLAB listed on?
MOREPENLAB is listed on NS.
What is Morepen Laboratories Ltd's net margin?
Morepen Laboratories Ltd (MOREPENLAB) reports a net margin of 5.8% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.